Skip to main content

Table 1 List of bioassays used for characterization in the initial screen and result summary

From: An extensive phenotypic characterization of the hTNFα transgenic mice

Therapeutic Field

Bioassays

Phenotype

Cardiovascular, renal and bladder function

Bladder function (F)

NS

 

Blood pressure/heart rate (M)

↑(BP)*

 

Urine chemistry panel (F)

NS

CNS and Behavior

Irwin test (M,F)

↓***

Cross-therapeutic assays

Automated blood chemistry panel (M)

NS

 

Body weight measurements (M,F)

NS

 

Corticosterone (M)

↑*

Immunology and Inflammation

DTH (M)

NS

 

FACS analysis (M)

↓*

 

LPS challenge (M)

NS

 

Monocyte infiltration (F)

↑*

 

Pulmonary inflammation (F)

NS

 

Wound healing (F)

NS

Metabolism and Body Composition

DEXA (F)

↓*

 

Excised bone DEXA (F)

↓**

 

Food intake (M,F)

NS

 

Food intake on HFD (M)

↑***

 

Leptin (M,F)

↓**

 

Metabolic response to HFD (M)

↑**

 

Physical response to HFD (M)

↓***

 

Selected muscle weight (F)

↓**

Pain

Formalin pain assay (M)

NS

 

Hot-plate assay (F)

NS

Sexual health

Histopathology of reproductive system (M)

NS

 

Induced erection test (M)

↓*

 

Male contact sexual behavior (M)

↓***

 

Male fertility (M)

↓***

 

Testosterone (M)

NS

  1. The highest levels of significance among all measures measured in the assay are shown by asterisks: * P < 0.05, ** 0.001 < P < 0.01, *** P < 0.001 and arrows indicate measurements in the TG line increased or decreased from WT. No significant difference between genotypes (NS), males (M), females (F), delayed-type hypersensitivity (DTH), fluorescence-activated cell sorting (FACS), lipopolysaccharide (LPS), Dual energy X-ray analysis (DEXA) high fat diet (HFD).